{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:45:45Z","timestamp":1789577145492,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":508,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"crossref","award":["FAPESP 08\/09260-7"],"award-info":[{"award-number":["FAPESP 08\/09260-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.exppara.2012.01.010","type":"journal-article","created":{"date-parts":[[2012,1,25]],"date-time":"2012-01-25T11:13:50Z","timestamp":1327490030000},"page":"195-199","source":"Crossref","is-referenced-by-count":45,"title":["Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi"],"prefix":"10.1016","volume":"130","author":[{"given":"Juliana Q.","family":"Reim\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio A.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera L.","family":"Pereira-Chioccola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 G.","family":"Tempone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2012.01.010_b0005","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/507530","article-title":"Liposomal amphotericin B for the treatment of visceral leishmaniasis","volume":"43","author":"Bern","year":"2006","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.exppara.2012.01.010_b0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00436-010-2247-6","article-title":"Detection of Leishmania (Leishmania) infantum RNA in fleas and ticks collected from naturally infected dogs","volume":"109","author":"Colombo","year":"2011","journal-title":"Parasitology Research"},{"key":"10.1016\/j.exppara.2012.01.010_b0015","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jac\/30.6.827","article-title":"The activity of hydroxynaphthoquinones against Leishmania donovani","volume":"30","author":"Croft","year":"1992","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.exppara.2012.01.010_b0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/14728210903153862","article-title":"Developments in the treatment of visceral leishmaniasis","volume":"14","author":"den Boer","year":"2009","journal-title":"Expert Opinion on Emerging Drugs"},{"issue":"7","key":"10.1016\/j.exppara.2012.01.010_b0025","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1517\/17425247.2010.529897","article-title":"New delivery strategies for the old pentavalent antimonial drugs","volume":"2010","author":"Fr\u00e9zard","year":"2010","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.exppara.2012.01.010_b0030","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/jac\/dkm303","article-title":"In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs","volume":"60","author":"Garnier","year":"2007","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.exppara.2012.01.010_b0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0162-0134(03)00134-X","article-title":"Transition metal complexes of buparvaquone as potent new antimalarial agents. 1. Synthesis, X-ray crystal-structures, electrochemistry and antimalarial activity against Plasmodium falciparum","volume":"95","author":"Gokhale","year":"2003","journal-title":"Journal of Inorganic Biochemistry"},{"key":"10.1016\/j.exppara.2012.01.010_b0040","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/CMR.6.3.230","article-title":"Leishmaniases of the New World: current concepts and implications for future research","volume":"6","author":"Grimaldi","year":"1993","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1016\/j.exppara.2012.01.010_b0045","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/157489108786242341","article-title":"Visceral leishmaniasis: advances in treatment","volume":"3","author":"Maltezou","year":"2008","journal-title":"Recent Patents on Anti-infective Drug Discovery"},{"key":"10.1016\/j.exppara.2012.01.010_b0050","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1196\/annals.1428.018","article-title":"Leishmania DNA quantification by real-time PCR in naturally infected dogs treated with miltefosine","volume":"1149","author":"Manna","year":"2008","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.exppara.2012.01.010_b0055","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1021\/jm030868a","article-title":"Synthesis, in vitro evaluation and antileishmanial activity of water-soluble prodrugs of buparvaquone","volume":"47","author":"M\u00e4ntyl\u00e4","year":"2004","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.exppara.2012.01.010_b0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0378-5173(02)00040-6","article-title":"Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability","volume":"237","author":"M\u00fcller","year":"2002","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.exppara.2012.01.010_b0065","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.45.8.2185-2197.2001","article-title":"Clinical and experimental advances in treatment of visceral leishmaniasis","volume":"45","author":"Murray","year":"2001","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.exppara.2012.01.010_b0070","series-title":"Liposomes: A Practical Approach","author":"New","year":"1992"},{"key":"10.1016\/j.exppara.2012.01.010_b0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.exppara.2011.02.021","article-title":"In vitro and experimental therapeutic studies of the calcium channel blocker bepridil: Detection of viable Leishmania (L.) chagasi by real-time PCR","volume":"128","author":"Reim\u00e3o","year":"2011","journal-title":"Experimental Parasitology"},{"key":"10.1016\/j.exppara.2012.01.010_b0080","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00436-010-1826-x","article-title":"Furazolidone is a selective in vitro candidate against Leishmania (L.) chagasi: an ultrastructural study","volume":"106","author":"Reim\u00e3o","year":"2010","journal-title":"Parasitolology Research"},{"key":"10.1016\/j.exppara.2012.01.010_b0085","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jac\/dkr185","article-title":"Study of parasite kinetics with antileishmanial drugs using real-time quantitative PCR in Indian visceral leishmaniasis","volume":"66","author":"Sudarshan","year":"2011","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.exppara.2012.01.010_b0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.trstmh.2010.10.008","article-title":"Ambisome plus miltefosine for Indian patients with kala-azar","volume":"105","author":"Sundar","year":"2011","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.exppara.2012.01.010_b0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0022-1759(86)90183-3","article-title":"An improved colorimetric assay for interleukin 2","volume":"93","author":"Tada","year":"1986","journal-title":"Journal of Immunological Methods"},{"key":"10.1016\/j.exppara.2012.01.010_b0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijantimicag.2010.04.006","article-title":"Therapeutic evaluation of free and liposome-loaded furazolidone in experimental visceral leishmaniasis","volume":"36","author":"Tempone","year":"2010","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1016\/j.exppara.2012.01.010_b0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jac\/dkh281","article-title":"Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine","volume":"54","author":"Tempone","year":"2004","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.exppara.2012.01.010_b0110","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.meegid.2010.05.006","article-title":"Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes","volume":"10","author":"Torres","year":"2010","journal-title":"Infection, Genetics and Evolution"},{"key":"10.1016\/j.exppara.2012.01.010_b0115","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/bmc.965","article-title":"Optimization and validation of RP-HPLC-UV method with solid-phase extraction for determination of buparvaquone in human and rabbit plasma: application to pharmacokinetic study","volume":"22","author":"Venkatesh","year":"2008","journal-title":"Biomedical Chromatography"},{"key":"10.1016\/j.exppara.2012.01.010_b0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-4017(96)01150-8","article-title":"Failure of buparvaquone (Butalex) in the treatment of canine visceral leishmaniosis","volume":"77","author":"Vexenat","year":"1998","journal-title":"Veterinary Parasitology"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489412000276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489412000276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T22:26:58Z","timestamp":1543271218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489412000276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0014489412000276"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2012.01.010","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}